When people talk about the biology of low mood, the conversation almost always goes straight to serotonin and dopamine. But there’s a quieter, less-discussed piece of the puzzle: your immune system. Genetics is only one factor among many here — sleep, chronic stress, and physical health all play a role too — but a growing body of research links low-grade inflammation, and the genes that regulate it, such as CRP, to depressive symptoms. A large UK Biobank and NESDA cohort study found that genetically predicted higher activity in an inflammatory pathway was associated with increased risk of low mood, fatigue, and sleep disturbance (Kappelmann et al., 2021). It’s a real and active area of research, not a settled fact.
CRP and a Genuinely Puzzling Set of Findings
C-reactive protein, or CRP, is a marker your liver produces during inflammation, and it’s one of the most-studied links between the immune system and mood. The gene that codes for it comes with a complication worth understanding honestly rather than glossing over.
Two Variants, Two Different Stories
A large study of men over 70 found that one CRP gene variant (rs1130864) was tied to higher circulating CRP levels but showed no direct link to depression risk. A second variant in the same gene (rs1205), however, was associated with a 70% higher risk of depression — while actually being tied to lower CRP levels in the blood (Almeida et al., 2009). That’s a genuinely strange result, and the study’s authors were upfront that it complicates any simple story where more inflammation genes equal more depression. It suggests the CRP gene may influence mood through a pathway that isn’t just about how much CRP ends up in your bloodstream.
What Larger Population Studies Show
A more recent analysis of over 57,000 people found that a genetic risk score for CRP was linked to greater negative affect and to anxiety disorder risk, and separately, a related inflammatory marker called GlycA showed a genetic association with major depressive disorder (Milaneschi et al., 2024). The authors were careful to note that inflammation seems to affect a broad range of mood-related symptoms rather than depression alone, and that the underlying mechanisms are still being worked out.
The IL-6 Pathway and Specific Symptom Patterns
Interleukin-6 (IL-6) is a signaling protein your immune cells release during inflammation, and unlike CRP, its genetic link to mood symptoms has held up fairly consistently across large datasets. Using a method called Mendelian randomization, which helps distinguish cause from mere correlation, researchers analyzing over 147,000 UK Biobank participants and a separate Dutch cohort found that genetically predicted higher IL-6 pathway activity was specifically associated with increased fatigue and sleep problems, with the pathway overall showing evidence of a possible causal role in depression (Kappelmann et al., 2021). Notably, the association was stronger for these somatic, energy-related symptoms than for core emotional symptoms like sadness itself — a distinction that’s easy to miss if you only skim the headlines.
Where the Evidence Doesn’t Hold Up: TNF-α
Not every inflammatory gene lives up to its early promise, and it’s worth saying so plainly. Tumor necrosis factor-alpha (TNF-α) was, for years, one of the most studied candidate genes in depression research. But a comprehensive meta-analysis pooling nearly a thousand depressed patients and over 2,600 controls found no significant association between the common TNF-α G-308A variant and depression risk, in any subgroup tested (Wang et al., 2020). Earlier individual studies had suggested a link, which is a good reminder that a single positive study doesn’t settle a question, and that inflammation’s role in mood is likely carried by specific pathways rather than by inflammation as one undifferentiated force.
The Non-Genetic Drivers of Inflammation-Linked Mood Changes
Chronic low-grade inflammation doesn’t only come from genetics. Poor sleep, a diet heavy in processed foods, sedentary habits, excess body fat, smoking, and untreated chronic illness can all raise inflammatory markers over time, and in turn may contribute to low mood independent of anyone’s genetic makeup. This is one of the more actionable angles in mood research: even for someone with a genetic tendency toward higher inflammatory signaling, addressing these everyday contributors can meaningfully shift the picture, and a persistent low mood always warrants a conversation with a doctor to rule out treatable medical causes.
Where Genetic Testing Fits In
If you’re wondering whether your own biology leans toward this inflammation-mood pathway, a comprehensive mood and mental health genetic report covers markers like these alongside the more familiar serotonin and dopamine story, giving a fuller picture than either angle alone. It won’t diagnose anything, but it can highlight which biological threads are worth discussing with a healthcare provider.
Frequently Asked Questions
Does inflammation cause depression?
The relationship appears to run in both directions and isn’t fully settled. Some studies find inflammation may contribute to depressive symptoms, while depression itself can also raise inflammatory markers. Genetics is one piece of a much larger, still-developing picture.
Should I take anti-inflammatory supplements or medications for low mood?
Talk to a doctor before starting anything new. Current research on inflammation and mood is not yet at the stage where it supports specific supplement or medication recommendations for the general public.
Is CRP testing the same as genetic testing?
No. A blood CRP test measures your current inflammation level, which changes day to day. Genetic testing looks at inherited variants that may influence how your body regulates inflammation and its downstream effects over your lifetime.
